116 results on '"Garsky, Victor M"'
Search Results
2. Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus
3. Aspartyl β -hydroxylase: In vitro Hydroxylation of a Synthetic Peptide Based on the Structure of the First Growth Factor-Like Domain of Human Factor IX
4. Chemical Synthesis of Echistatin, a Potent Inhibitor of Platelet Aggregation from Echis carinatus: Synthesis and Biological Activity of Selected Analogs
5. Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier
6. Two tarantula peptides inhibit activation of multiple sodium channels
7. Thermodynamics of peptide inhibitor binding to HIV-1 gp41
8. A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo
9. Blockers of the Delayed-Rectifier Potassium Current in Pancreatic β-Cells Enhance Glucose-Dependent Insulin Secretion
10. Three-dimensional structure of echistatin and dynamics of the active site
11. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys
12. Progress Towards the Development of a HIV-1 gp41-Directed Vaccine
13. Solution structure of the cytoplasmic domain of phospholamban: phosphorylation leads to a local perturbation in secondary structure
14. Identification and characterization of variants of tick anticoagulant peptide with increased inhibitory potency toward human factor Xa
15. Site-directed analysis of the functional domains in the factor Xa inhibitor tick anticoagulant peptide: identification of two distinct regions that constitute the enzyme recognition sites
16. Enhancement of α-Helicity in the HIV-1 Inhibitory Peptide DP178 Leads to an Increased Affinity for Human Monoclonal Antibody 2F5 but Does Not Elicit Neutralizing Responses in Vitro: IMPLICATIONS FOR VACCINE DESIGN
17. Structural Studies on Phospholamban and Implications for Regulation of the Ca2+-ATPase
18. Synthesis and characterization of tick anticoagulant peptide
19. The Pro Domain of β-Secretase Does Not Confer Strict Zymogen-like Properties but Does Assist Proper Folding of the Protease Domain
20. Reversal of acid-induced and inflammatory pain by the selective ASIC3 inhibitor, APETx2
21. Design and comparison of nonpeptide and peptide CCK antagonists
22. Depressor Response to Endothelin in Normotensive and Hypertensive Rats
23. Reversal of acid-induced and inflammatory pain by the selective ASIC3 inhibitor, APETx2
24. Rational design and synthesis of selective BACE-1 inhibitors
25. Enhancement of α-helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design.
26. Design and Synthesis of a Pro-Drug of Vinblastine Targeted at Treatment of Prostate Cancer with Enhanced Efficacy and Reduced Systemic Toxicity
27. The Synthesis of a Prodrug of Doxorubicin Designed to Provide Reduced Systemic Toxicity and Greater Target Efficacy
28. Synthesis and Characterization of Tick Anticoagulant Peptide
29. Selective Inhibition of Factor Xa in the Prothrombinase Complex by the Carboxyl-terminal Domain of Antistasin
30. Effects of Simultaneous Expression of Two Sodium Channel Toxin Genes on the Properties of Baculoviruses as Biopesticides
31. Mutational Anatomy of an HIV-1 Protease Variant Conferring Cross-resistance to Protease Inhibitors in Clinical Trials
32. Biochemical and Biophysical Comparison of Native and Chemically Synthesized Phospholamban and a Monomeric Phospholamban Analog
33. Development of 1,4-benzodiazepine cholecystokinin type B antagonists
34. Inhibition of Osteoclastic Bone Resorption in Vivo by Echistatin, an “Arginyl-Glycyl-Aspartyl” (RGD)-Containing Protein
35. Site-directed analysis of the functional domains in the factor Xa inhibitor tick anticoagulant peptide: identification of two distinct regions that constitute the enzyme recognition sites. [Erratum to document cited in CA117(25):247598n]
36. Invertebrate aspartyl/asparaginyl β-hydroxylase: Potential modification of endogenous epidermal growth factor-like modules
37. Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural product
38. Proton NMR assignments and secondary structure of the snake venom protein echistatin
39. The bovine endothelin receptor has an apparent molecular weight of 43 000
40. Prevention of Reocclusion following Tissue Type Plasminogen Activator-Induced Thrombolysis by the RGD-Containing Peptide, Echistatin, in a Canine Model of Coronary Thrombosis
41. Prevention of Canine Coronary Artery Thrombosis with Echistatin, a Potent Inhibitor of Platelet Aggregation from the Venom of the Viper, Echis carmatus
42. A peptide?doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo.
43. Protective effect of a synthetic peptide comprising the complete pres2 region of the hepatitis b virus surface protein.
44. Ras interaction with the GTPase-activating protein (GAP).
45. Structural Studies on Phospholamban and Implications for Regulation of the Ca2+-ATPase.
46. Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design.
47. PSA-Specific and Non-PSA-Specific Conversion of a PSA-Targeted Peptide Conjugate of Doxorubicin to Its Active Metabolites
48. HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins
49. Prominent depressor response to endothelin in spontaneously hypertensive rats
50. Minimal Ligand Analysis of Gastrin-Releasing Peptide: Receptor Binding and Mitogenesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.